Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grabowski, C. M.
Right arrow Articles by Potish, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grabowski, C. M.
Right arrow Articles by Potish, R. A.

Radiology, Vol 184, 329-332, Copyright © 1992 by Radiological Society of North America


ARTICLES

Factors predictive of completion of treatment and survival after palliative radiation therapy

CM Grabowski, JA Unger and RA Potish
Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota Hospital and Clinic, Minneapolis 55455.

Ninety-seven patients who underwent radiation treatment for metastatic carcinomas and sarcomas were evaluated to define prognostic factors that may reliably help determine survival and probability of completing a course of palliative radiation therapy. Actuarial and logistic models were used for analysis. Predictor variables included age; sex; symptoms; primary site of disease; pathologic diagnosis; prior metastatic disease, treatment, and response; solitary versus multiple metastatic sites; location of metastasis; status of primary lesion; interval between initial diagnosis and treatment for metastatic disease; and Karnofsky performance score (KPS). The interval between primary diagnosis and metastatic treatment, and KPS, were significant variables for 22 patients (23%) who failed to complete their planned radiation treatment. KPS was consistently significant for probability of survival at 2-, 4-, 8-, and 16-month intervals. At 8 months and 16 months, site of primary disease was significant, and at 16 months, solitary site of metastasis was also significant. Conventional factors, especially KPS, are useful in predicting the likelihood of completing radiation therapy and of subsequent survival for patients undergoing palliative treatment.


This article has been cited by other articles:


Home page
Eval Health ProfHome page
K. S. Chan and D. A. Revicki
Changes in Surrogate Laboratory Markers, Clinical Endpoints, and Health-Related Quality of Life in Patients Infected with the Human Immunodeficiency Virus
Eval Health Prof, June 1, 1998; 21(2): 265 - 281.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1992 by the Radiological Society of North America.